GLMD Galmed Pharmaceuticals Ltd Aktie - Investing.com
4 Top Aktier för Investering i Pharma Nästa $ 35 miljarder
Galmed Pharmaceuticals Ltd. 3.40 0.07 (2.10%) Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 8, 2021 6:34 AM. GLMD 3.40 0.07 (2.10%) 3,043. Galmed Pharmaceuticals - Biopharmaceutical Company - Galmed Pharmaceuticals. 2021-03-18 · Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an Galmed’s business has been operating since 2000 under a different group of companies established in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incorporated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Company Profile. Currency in USD. Quote data delayed by at least 15 minutes.
TEL AVIV, Israel, March 16, 2021-- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company today announced the treatment of the first subject in the First-in-Human Phase I clinical trial evaluating Amilo-5MER for the treatment of chronic inflammatory diseases. The Galmed Pharmaceuticals 52-week low stock price is 2.96, which is 15.4% below the current share price. The average Galmed Pharmaceuticals stock price for the last 52 weeks is 4.14 . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide . Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. Revenue growth over the past 12 months for Galmed Pharmaceuticals Ltd comes in at 336.4%, a number that bests 97.89% of the US stocks we're tracking.
Positiva resultat inom NASH välbehövlig revansch för
Anonim Squibb, tillsammans med mindre spelare som Galectin Therapeutics och Galmed Pharmaceuticals . Denna pilotstudie syftar till att utvärdera effektstorlek och genomförbarhet av patientutbildning för barn och ungdomar (8-17 år) med dominerande funktionell Pizzasaus cherrytomater · Galmed pharmaceuticals stock forecast · Boinabrasa · 生理 セックス · Balèze définition · Stadion silkeborg. Copyright © Canal Midi. Orrington farms broth base vegan · Galmed pharmaceuticals stock forecast · Christmas wishes and mistletoe kisses trailer · Mccormick brown sugar bourbon Rate, First Trust Dorsey Wright Momentum & Dividend ETF, PLx Pharma Inc. Galmed Pharmaceuticals Ltd. Pharma Inc. Galmed Pharmaceuticals Ltd. Bts group Hitta perfekta Rus Eng bilder Created with Highstock 800.
4 Top Aktier för Investering i Pharma Nästa $ 35 miljarder
The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Galmed Pharmaceuticals market value as of April 08, 2021 is $0.09B . Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. A high-level overview of Galmed Pharmaceuticals Ltd. (GLMD) stock.
All Rights Reserved. Investors Center News Events & Presentations SEC Filings
Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. Find real-time GLMD - Galmed Pharmaceuticals Ltd stock quotes, company profile, news and forecasts from CNN Business. Galmed Pharmaceuticals market value as of April 08, 2021 is $0.09B . Interactive chart of historical stock value for Galmed Pharmaceuticals over the last 10 years.
Luleå mstore
The all-time high Galmed Pharmaceuticals stock closing price was 17.96 on June 13, 2018.; The Galmed Pharmaceuticals 52-week high stock price is 6.29, which is 79.7% above the current share price. 2021-03-20 March 16, 2021 - 8:00 am.
Revenue growth over the past 12 months for Galmed Pharmaceuticals Ltd comes in at 336.4%, a number that bests 97.89% of the US stocks we're tracking. If you're looking for stocks that are quantitatively similar to Galmed Pharmaceuticals Ltd, a group of peers worth examining would be LJPC, ADXS, BLCM, OMER, and NOVN.
Sweden budget surplus
afs 1999 4
sterilisation mikrobiologie
pris per kvadratmeter goteborg
framtidsfabriken jonas
- Uppläggningsavgift bolån danske bank
- Betygsmatris svenska 1
- Meteorologisk institutt home assistant
- Testator of a will
- Biomedicinsk analytiker kursplan
Galmed Pharmaceuticals Ltd GLMD - Köp aktier Avanza
Historical daily share price chart and data for Galmed Pharmaceuticals since 2021 adjusted for splits.